ARQT · NASDAQ · Biotechnology

Arcutis Biotherapeutics

Develops ZORYVE topical treatments for plaque psoriasis, atopic dermatitis, and seborrheic dermatitis.

$23.74
After-hours close−0.03 (−0.13%)
At close$23.77(−4.42%)
DateEstimateReportedSurprise
Oct 2026$0.17
Aug 2026$0.06$0.11+99.7%
May 2026−$0.02−$0.09−350.0%
Feb 2026$0.03$0.13+333.3%
Oct 2025−$0.10$0.06+160.0%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Jan 2020
Jun 2019
Mar 2019
Dec 2018
Sep 2018
Jun 2018
Mar 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 27, 2026$0.17$141.0M
Aug 5, 2026$0.06$0.11+99.7%$118.9M$129.9M+9.3%
May 6, 2026−$0.02−$0.09−350.0%$103.7M$105.4M+1.7%
Feb 25, 2026$0.03$0.13+333.3%$113.1M$129.5M+14.5%
Oct 28, 2025−$0.10$0.06+160.0%$110.8M$99.2M−10.4%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
Aug 6, 2025
May 6, 2025
Feb 25, 2025
Nov 6, 2024
Aug 14, 2024
May 14, 2024
Feb 27, 2024
Nov 3, 2023
Aug 8, 2023
May 9, 2023
Feb 28, 2023
Nov 8, 2022
Aug 4, 2022
May 5, 2022
Feb 22, 2022
Nov 4, 2021
Aug 5, 2021
May 4, 2021
Feb 16, 2021
Nov 5, 2020
Aug 11, 2020
May 12, 2020
Mar 19, 2020
Jan 31, 2020
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018